Most Popular
-
1
Yoon’s jailed mother-in-law excluded from latest parole list
-
2
[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
3
Korea’s homegrown nanosatellite successfully launches into space
-
4
Nicaragua shuts down Seoul embassy
-
5
Rocket engine expert, ex-NASA exec to lead Korea's new space agency
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
6
SNU profs to suspend treatment for one day
-
7
SK hynix pledges W20tr to ramp up DRAM production at home
-
8
Hybe's multilabel system tested amid conflict with Ador
-
9
Aging population to drive down Korea's housing prices from 2040: experts
-
10
Over-50s, men, single-person households take up majority of those filing for bankruptcy
LG Chem obtains approval for sale of biosimilar etanercept in Japan
By YonhapPublished : Jan. 19, 2018 - 20:27
LG Chem Ltd., South Korea's leading chemical company, said Friday that it has obtained Japanese approval to sell its biosimilar etanercept for the treatment of rheumatoid arthritis.
The Japanese Ministry of Health, Labor and Welfare has approved LG Chem's new drug, which is biosimilar to Amgen Inc.'s Enbrel.
LG Chem said it will produce the biosimilar at its plant in South Korea before shipping it to two Japanese distributers, Mochida Pharmaceutical Co. and Ayumi Pharmaceutical Corp.
The Japanese Ministry of Health, Labor and Welfare has approved LG Chem's new drug, which is biosimilar to Amgen Inc.'s Enbrel.
LG Chem said it will produce the biosimilar at its plant in South Korea before shipping it to two Japanese distributers, Mochida Pharmaceutical Co. and Ayumi Pharmaceutical Corp.
The biosimilar, whose brand name has not been announced, could hit the shelves in Japan around May, an official of LG Chem said.
A biosimiliar is a biologic medical product which is almost an identical copy of an original product manufactured by a different company. (Yonhap)
